Form 4 for GH Guardant Health, Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001576280-25-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-04 | 2025-03-01 | GH | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +5,686 | 40.4K | +16% | $0 |
| D | 2025-03-04 | 2025-03-01 | GH | Freeman Chris | Chief Commercial Off | F - Tax | $42.55 | -1,566 | 38.8K | -4% | -$66.6K |
| D | 2025-03-04 | 2025-03-01 | GH | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | -5,686 | 11.4K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | M | A | 5,686 | $0.00 | 40,355 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-01 | F | D | 1,566 | $42.55 | 38,789 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 3 | Derivative | Performance-Based Restricted Stock Units | 2025-03-01 | M | D | 5,686 | $0.00 | 11,376 | D | $0.00 · — to — | 5,686 Common Stock | (F2) This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027. (F3) Not applicable for Restricted Stock Units. |